Kalaris Therapeutics (KLRS) Consolidated Net Income (2019 - 2026)
Kalaris Therapeutics (KLRS) posted Consolidated Net Income of -$12.39 million for Q2 2026, compared with -$12.26 million a year earlier.
Powered by 
Analysis
Kalaris Therapeutics (KLRS) Consolidated Net Income (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Consolidated Net Income at Kalaris Therapeutics was -$47.76 million; for FY2025, it was -$47.6 million.
- In prior years, Kalaris Therapeutics' Consolidated Net Income was -$58.77 million in FY2024, -$190.42 million in FY2023, -$168.71 million in FY2022 and -$171.96 million in FY2021.
- Quarterly Consolidated Net Income has run from a low of -$59.7 million in Q4 2023 to a high of -$1.4 million in Q1 2024 over five years.
- According to Business Quant data, Consolidated Net Income for the three prior quarters was -$11.83 million (Q1 2026), -$10.8 million (Q4 2025) and -$12.74 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Kalaris Therapeutics | 64.27 Mn | 64.27 Mn | - | -12.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -12.39 Mn |
| Mar 31, 2026 | -11.83 Mn |
| Dec 31, 2025 | -10.80 Mn |
| Sep 30, 2025 | -12.74 Mn |
| Jun 30, 2025 | -12.26 Mn |
| Mar 31, 2025 | -11.80 Mn |
| Dec 31, 2024 | -7.06 Mn |
| Sep 30, 2024 | -37.17 Mn |
| Jun 30, 2024 | -3.33 Mn |
| Mar 31, 2024 | -1.40 Mn |
| Dec 31, 2023 | -59.70 Mn |
| Sep 30, 2023 | -44.27 Mn |
| Jun 30, 2023 | -45.27 Mn |
| Mar 31, 2023 | -41.91 Mn |
| Dec 31, 2022 | -38.09 Mn |
| Sep 30, 2022 | -42.07 Mn |
| Jun 30, 2022 | -44.69 Mn |
| Mar 31, 2022 | -43.86 Mn |
| Dec 31, 2021 | -56.93 Mn |
| Sep 30, 2021 | -45.51 Mn |
API Access
Kalaris Therapeutics Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=KLRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "KLRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=KLRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();